Visient Therapeutics, Inc. Appoints Ophthalmologist David A. Saperstein To Scientific Advisory Board
10/19/2005 5:13:01 PM
More...
|
Visient Therapeutics, Inc. Treats First Patient In Phase 1 Trial Of Litx(TM) For Advanced Age-Related Macular Degeneration
10/19/2005 5:12:50 PM
More...
|
Light Sciences Announces Three Spin-Off Companies
10/19/2005 5:12:01 PM
More...
|